Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia.

NCT01571635 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

46

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Beta Thalassemia Major
Beta Thalassemia Intermedia

Interventions

DRUG: SOTATERCEPT (ACE-011)

Sponsor

Celgene